who is running for president next year

fashion

author：knowledge 2025-09-06 01:59:38 - browse：28

Stock exchange — Drew Angerer/Getty Images

Sage Therapeutics said Monday that it may need to reduce costs, including through employee layoffs, following the Food and Drug Administration’s denial of its rapid-acting drug for major depressive disorder.

On Friday, the agency granted market clearance for the drug, called Zurzuvae, to treat women with postpartum depression, a smaller commercial market. Sage failed to convince regulators to also approve the drug for depression, a broader condition.

“We don’t agree with the FDA review,” Sage CEO Barry Greene said during an earnings call, a point he made repeatedly. “We are evaluating the [FDA’s response letter] and as soon as we can provide more clarity, we will, on what the next steps are.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： U.K. decision on ALS drug has neurologists, advocates up in arms

hotspot

WSS

The debate over Covid

Companies helping big Covid

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Wikipedia

fashion

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Walensky prepares to leave CDC — and Congress — behind

Study: Black kids more likely to die after surgery than white kids

Sports medicine is finally prioritizing gender equality

First Opinion on colorectal cancer screening: letter and response

Activists slam private health insurers over coverage restrictions

A Greenpeace activist is fined for crash

The cancer drug shortage isn’t new — and neither are the solutions

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

hotspot

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Four alarming medical procedures we’re glad history forgot

Harvard scientists, with Google, unveil the most detailed brain map ever

Superbugs, antibiotic resistance get scrutiny in congress

Republican states more likely to report Covid vaccine side effects

knowledge

leisure time

hotspot

entertainment